You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 145 No. 5, May 1985 TABLE OF CONTENTS
  Archives
  •  Online Features
  ORIGINAL INVESTIGATIONS
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (75)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

The Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome

Catherine Butkus Small, MD; Carol A. Harris, MD; Gerald H. Friedland, MD; Robert S. Klein, MD

Arch Intern Med. 1985;145(5):837-840.


Abstract

• Forty-four episodes of Pneumocystis carinii pneumonia (PCP) occurred in 36 of 70 patients with the acquired immunodeficiency syndrome. Thirty-four patients with 40 episodes of PCP were treated with trimethoprim-sulfamethoxazole. Therapy was successful in 18 episodes (45%), but was unsuccessful in 15 episodes (37.5%). In the latter cases, two patients died within 72 hours; 13, of whom nine died, had therapy changed to pentamidine. In seven additional episodes (17.5%), trimethoprim-sulfamethoxazole was changed to pentamidine due to adverse reactions; all patients survived. Seven patients (26% of survivors) developed recurrent PCP. Twenty-two patients (65%) developed adverse reactions to trimethoprim-sulfamethoxazole, including leukopenia (20), hepatotoxicity (12), fever (eight), rash (six), and immediate reactions (two). Reactions were most common during the second week of therapy. Patients with the acquired immunodeficiency syndrome who have PCP have a high trimethoprim-sulfamethoxazole failure rate, due either to adverse reactions or unresponsive infection. Late recurrence is common.

(Arch Intern Med 1985;145:837-840)



Author Affiliations

From the Division of Infectious Diseases, Department of Medicine, Montefiore Medical Center and North Central Bronx Hospital (Drs Small, Harris, Friedland, and Klein), and the Department of Medicine, Albert Einstein College of Medicine (Drs Small, Harris, Friedland, and Klein), Bronx, NY. Dr Small is now with the Westchester County Medical Center, Valhalla, NY.


Footnotes

Accepted for publication Sept 21, 1984.

Read in part before the 23rd Interscience Conference on Antimicrobial Agents and Chemotherapy, Las Vegas, Oct 25, 1983.

Reprint requests to Division of Infectious Diseases, Montefiore Medical Center, 111 E 210th St, Bronx, NY 10467 (Dr Klein).



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Increased Adverse Drug Reactions to Antimicrobials and Anticonvulsants in Patients with HIV Infection
Lin et al.
The Annals of Pharmacotherapy 2006;40:1594-1601.
ABSTRACT | FULL TEXT  

Management of Adverse Reactions to Trimethoprim-Sulfamethoxazole in Human Immunodeficiency Virus--Infected Patients
Jung and Paauw
Arch Intern Med 1994;154:2402-2406.
ABSTRACT  

Adverse Cutaneous Reactions to Trimethoprim-Sulfamethoxazole in Patients With the Acquired Immunodeficiency Syndrome and Pneumocystis carinii Pneumonia
Roudier et al.
Arch Dermatol 1994;130:1383-1386.
ABSTRACT  

Aerosolized Pentamidine: Effect on Diagnosis and Presentation of Pneumocystis carinii Pneumonia
Jules-Elysee et al.
ANN INTERN MED 1990;112:750-757.
ABSTRACT  

Pneumocystis carinii Pneumonia in Human Immunodeficiency Virus-Infected Patients
Glatt and Chirgwin
Arch Intern Med 1990;150:271-279.
ABSTRACT  

Serum Triiodothyronine Values: Prognostic Indicators of Acute Mortality due to Pneumocystis carinii Pneumonia Associated With the Acquired Immunodeficiency Syndrome
Fried et al.
Arch Intern Med 1990;150:406-409.
ABSTRACT  

Trimethoprim-Sulfamethoxazole Compared with Pentamidine for Treatment of Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome: A Prospective, Noncrossover Study
Sattler et al.
ANN INTERN MED 1988;109:280-287.
ABSTRACT  

Empirical Diagnosis of Pneumocystis carinii Pneumonia-Reply
Chaisson and Hopewell
JAMA 1988;259:2850-2850.
ABSTRACT  

Cutaneous Reactions to Trimethoprim-Sulfamethoxazole in African Patients with the Acquired Immunodeficiency Syndrome
COLEBUNDERS et al.
ANN INTERN MED 1987;107:599-600.
ABSTRACT  

Early Predictors of In-Hospital Mortality for Pneumocystis carinii Pneumonia in the Acquired Immunodeficiency Syndrome
Kales et al.
Arch Intern Med 1987;147:1413-1417.
ABSTRACT  

Treatment of Patients With Acquired Immunodeficiency Syndrome and Associated Manifestations
Kaplan et al.
JAMA 1987;257:1367-1374.
ABSTRACT  

Intravenous Drug Abusers and HIV Infections: A Consequence of Their Actions
Ginzburg
J Law Med Ethics 1986;14:268-272.
 





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1985 American Medical Association. All Rights Reserved.